CD4+ Tem, CD8+ Tcm, CD8+ T-cells, CD8+ naive T-cells, and B cells were associated with better prognosis whereas CD4+ naive T-cells were negatively associated with prognosis for breast cancer patients. Here, CD8A is linked to breast cancer.